【摘要】 目的观察利凡诺在疤痕子宫中期妊娠患者引产中的临床应用效果及安全性。方法取2010年2月~2014年1月收治的136例疤痕子宫中期妊娠患者为研究对象(实验组),临床评估后均给予利凡诺药物作引产处理;取同期120例正常引产者为对照。观察两组出血量、引产成功率、胎盘娩出情况以及清宫率。结果与对照组相比,实验组胎盘娩出率以及清宫率更高,组间差异具有统计学意义(P<0.05);两组出血量、引产成功率并无明显差异(P>0.05)。结论对于疤痕子宫女性而言,一旦妊娠应立刻来院诊断,并尽量选择早孕期实施吸宫术终止妊娠,尽量避免中期妊娠引产;中期妊娠者应以利凡诺引产术为首选方案,安全性较高,但应严格遵循手术操作规程,确保引产质量与患者安全。更多还原

【Abstract】 Objective To observe the clinical application rivanol efficacy and safety in patients with uterine scar pregnancy in the second trimester abortion. Methods 136 cases of uterine scar trimester patients in our hospital from February 2010 to January 2014 were selected for the study( experimental group),which were given rivanol drugs as induction treatment after clinical assessment; while selected the same period 120 cases of normal abortion as controls.Bleeding and the success rate of abortion,as well as the placenta curettage rate were observed. Results Compared with the control group,the experimental group placenta and curettage rate were higher,there was statistical significance( P <0. 05); Bleeding and the success rate of labor induction of the two group had no significant difference( P > 0. 05).Conclusions For women with uterine scar,once the hospital diagnosis of pregnancy should be immediately and try to choose the implementation aspiration of uterus during early pregnancy termination of pregnancy to avoid trimester abortion; mid-pregnancy abortion should rivanol surgery is the preferred option,security higher,but surgical procedures should be strictly followed to ensure quality and patient safety induction.更多还原